You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

TAMSULOSIN HYDROCHLORIDE - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic drug sources for tamsulosin hydrochloride and what is the scope of freedom to operate?

Tamsulosin hydrochloride is the generic ingredient in two branded drugs marketed by Sanofi, Alkem Labs Ltd, Ascent Pharms Inc, Aurobindo Pharma Ltd, Chartwell Rx, Endo Operations, Impax Labs, Macleods Pharms Ltd, Norvium Bioscience, Sandoz, Sun Pharm Inds Ltd, Synthon Pharms, Teva Pharms, Wockhardt, and Zydus Pharms Usa Inc, and is included in fifteen NDAs. Additional information is available in the individual branded drug profile pages.

There are thirty-two drug master file entries for tamsulosin hydrochloride. Forty-four suppliers are listed for this compound.

Summary for TAMSULOSIN HYDROCHLORIDE
US Patents:0
Tradenames:2
Applicants:15
NDAs:15
Drug Master File Entries: 32
Finished Product Suppliers / Packagers: 44
Raw Ingredient (Bulk) Api Vendors: 109
Clinical Trials: 201
Patent Applications: 2,963
What excipients (inactive ingredients) are in TAMSULOSIN HYDROCHLORIDE?TAMSULOSIN HYDROCHLORIDE excipients list
DailyMed Link:TAMSULOSIN HYDROCHLORIDE at DailyMed
Recent Clinical Trials for TAMSULOSIN HYDROCHLORIDE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Hackensack Meridian HealthN/A
NorthShore University HealthSystemPhase 3
Benha UniversityN/A

See all TAMSULOSIN HYDROCHLORIDE clinical trials

Pharmacology for TAMSULOSIN HYDROCHLORIDE
Paragraph IV (Patent) Challenges for TAMSULOSIN HYDROCHLORIDE
Tradename Dosage Ingredient Strength NDA ANDAs Submitted Submissiondate
FLOMAX Capsules tamsulosin hydrochloride 0.4 mg 020579 1 2004-12-20

US Patents and Regulatory Information for TAMSULOSIN HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sun Pharm Inds Ltd TAMSULOSIN HYDROCHLORIDE tamsulosin hydrochloride CAPSULE;ORAL 090931-001 Jul 15, 2010 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Aurobindo Pharma Ltd TAMSULOSIN HYDROCHLORIDE tamsulosin hydrochloride CAPSULE;ORAL 202433-001 Apr 30, 2013 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Teva Pharms TAMSULOSIN HYDROCHLORIDE tamsulosin hydrochloride CAPSULE;ORAL 077630-001 Apr 27, 2010 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Norvium Bioscience TAMSULOSIN HYDROCHLORIDE tamsulosin hydrochloride CAPSULE;ORAL 090408-001 Apr 27, 2010 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Zydus Pharms Usa Inc TAMSULOSIN HYDROCHLORIDE tamsulosin hydrochloride CAPSULE;ORAL 078225-001 Apr 27, 2010 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for TAMSULOSIN HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Sanofi FLOMAX tamsulosin hydrochloride CAPSULE;ORAL 020579-001 Apr 15, 1997 ⤷  Sign Up ⤷  Sign Up
Sanofi FLOMAX tamsulosin hydrochloride CAPSULE;ORAL 020579-001 Apr 15, 1997 ⤷  Sign Up ⤷  Sign Up
Sanofi FLOMAX tamsulosin hydrochloride CAPSULE;ORAL 020579-001 Apr 15, 1997 ⤷  Sign Up ⤷  Sign Up
Sanofi FLOMAX tamsulosin hydrochloride CAPSULE;ORAL 020579-001 Apr 15, 1997 ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.